| Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection C Guiducci, AP Vicari, S Sangaletti, G Trinchieri, MP Colombo Cancer research 65 (8), 3437-3446, 2005 | 694 | 2005 |
| Tumor microenvironment complexity: emerging roles in cancer therapy MA Swartz, N Iida, EW Roberts, S Sangaletti, MH Wong, FE Yull, ... Cancer research 72 (10), 2473-2480, 2012 | 626 | 2012 |
| Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity S Sangaletti, C Tripodo, C Chiodoni, C Guarnotta, B Cappetti, P Casalini, ... Blood, The Journal of the American Society of Hematology 120 (15), 3007-3018, 2012 | 441 | 2012 |
| Amino-biphosphonate–mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor … C Melani, S Sangaletti, FM Barazzetta, Z Werb, MP Colombo Cancer research 67 (23), 11438-11446, 2007 | 393 | 2007 |
| Antibody–Fc/FcR interaction on macrophages as a mechanism for hyperprogressive disease in non–small cell lung cancer subsequent to PD-1/PD-L1 blockade G Lo Russo, M Moro, M Sommariva, V Cancila, M Boeri, G Centonze, ... Clinical Cancer Research 25 (3), 989-999, 2019 | 386 | 2019 |
| Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis C Chiodoni, MP Colombo, S Sangaletti Cancer and Metastasis Reviews 29, 295-307, 2010 | 265 | 2010 |
| Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis S Sangaletti, E Di Carlo, S Gariboldi, S Miotti, B Cappetti, M Parenza, ... Cancer research 68 (21), 9050-9059, 2008 | 243 | 2008 |
| Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9 C Guiducci, C Tripodo, M Gong, S Sangaletti, MP Colombo, RL Coffman, ... Journal of Experimental Medicine 207 (13), 2931-2942, 2010 | 216 | 2010 |
| RORC1 regulates tumor-promoting “emergency” granulo-monocytopoiesis L Strauss, S Sangaletti, FM Consonni, G Szebeni, S Morlacchi, MG Totaro, ... Cancer cell 28 (2), 253-269, 2015 | 188 | 2015 |
| WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer L Castagnoli, V Cancila, SL Cordoba-Romero, S Faraci, G Talarico, ... Oncogene 38 (21), 4047-4060, 2019 | 167 | 2019 |
| Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma S Sangaletti, A Stoppacciaro, C Guiducci, MR Torrisi, MP Colombo The Journal of experimental medicine 198 (10), 1475-1485, 2003 | 156 | 2003 |
| The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment E De Marchi, E Orioli, A Pegoraro, S Sangaletti, P Portararo, A Curti, ... Oncogene 38 (19), 3636-3650, 2019 | 154 | 2019 |
| Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers P Pittoni, C Tripodo, S Piconese, G Mauri, M Parenza, A Rigoni, ... Cancer research 71 (18), 5987-5997, 2011 | 153 | 2011 |
| Lipopolysaccharide or whole bacteria block the conversion of inflammatory monocytes into dendritic cells in vivo G Rotta, EW Edwards, S Sangaletti, C Bennett, S Ronzoni, MP Colombo, ... The Journal of experimental medicine 198 (8), 1253-1263, 2003 | 140 | 2003 |
| Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphoma S Sangaletti, C Tripodo, C Vitali, P Portararo, C Guarnotta, P Casalini, ... Cancer discovery 4 (1), 110-129, 2014 | 128 | 2014 |
| Osteopontin shapes immunosuppression in the metastatic niche S Sangaletti, C Tripodo, S Sandri, I Torselli, C Vitali, C Ratti, L Botti, ... Cancer research 74 (17), 4706-4719, 2014 | 127 | 2014 |
| Triggering CD40 on endothelial cells contributes to tumor growth C Chiodoni, M Iezzi, C Guiducci, S Sangaletti, I Alessandrini, C Ratti, ... The Journal of experimental medicine 203 (11), 2441-2450, 2006 | 103 | 2006 |
| Mesenchymal transition of high-grade breast carcinomas depends on extracellular matrix control of myeloid suppressor cell activity S Sangaletti, C Tripodo, A Santangelo, N Castioni, P Portararo, A Gulino, ... Cell reports 17 (1), 233-248, 2016 | 94 | 2016 |
| Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSCs C Porta, FM Consonni, S Morlacchi, S Sangaletti, A Bleve, MG Totaro, ... Cancer research 80 (13), 2874-2888, 2020 | 92 | 2020 |
| Circulating T-cell immunosenescence in patients with advanced non–small cell lung cancer treated with single-agent PD-1/PD-L1 inhibitors or platinum-based chemotherapy R Ferrara, M Naigeon, E Auclin, B Duchemann, L Cassard, JM Jouniaux, ... Clinical Cancer Research 27 (2), 492-503, 2021 | 91 | 2021 |
mario p colomboIstituto Nazionale Tumori, Milano, ItalyVerified email at istitutotumori.mi.it
